Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.
Press releases published on August 25, 2025
Aircraft Doors Market Size Expected to Reach $9.1 Billion by 2031
EIN Presswire
·
August 25, 2025
The aircraft doors market was valued at $5 billion in 2021, and is estimated to reach $9.1 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- Companies are focused on …
Marina Yachts Introduces Luxury Corporate Meetings and Team-Building Experiences on Dubai Waters
EIN Presswire
·
August 25, 2025
Transforming corporate culture: Marina Yachts now offers unique team-building …
Parawood Verso by Sinem Halli Wins Iron A' Design Award in Homeware Design Category
EIN Presswire
·
August 25, 2025
Innovative Wooden Wall Art Captures Attention of International Design Jury with Its Sustainable Approach and Artistic Vision COMO, CO, ITALY, August 25, 2025 /EINPresswire.com/ -- The A' Design Award, a highly respected and well-recognized award in the …
Global Leading Stone Machine Exporter Shines at Xiamen Stone Fair 2025 - ShuiNan Machinery
EIN Presswire
·
August 25, 2025
QUANZHOU, FUJIAN, CHINA, August 25, 2025 /EINPresswire.com/ -- The 25th China Xiamen International Stone Fair concluded successfully in March 2025, establishing itself once again as the premier platform for the global stone industry. Among the …
إكس أس دوت كوم تفوز بجائزة "أفضل أبحاث السوق" في معرض الهند المالي
EIN Presswire
·
August 25, 2025
UNITED ARAB EMIRATES, August 25, 2025 /Business News/ -- أعلنت مجموعة إكس أس العالمية "إكس أس دوت كوم" (XS.com)، الوسيط العالمي الرائد في مجال الخدمات المالية وتكنولوجيا أسواق المال، عن فوزها بجائزة "أفضل أبحاث السوق" في معرض الهند المالي (موني إكسبو …
Gas Turbine MRO Market to Reach $20.4 Billion by 2032, Driven by Power Generation Demand
EIN Presswire
·
August 25, 2025
Gas Turbine MRO Market Growth Fueled by Energy Transition and Predictive Maintenance Technologies WILMINGTON, DE, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- According to a recent report published by Allied Market Research, the Gas Turbine …
CASABOT Selected by 500 VC to Compete in Cityscape PropTech Challenge 2025
EIN Presswire
·
August 25, 2025
CASABOT has been selected by global venture capital firm 500 to participate in the International Growth stage category of the Cityscape PropTech Challenge 2025. DUBAI, UNITED ARAB EMIRATES, August 25, 2025 /EINPresswire.com/ -- CASABOT, the UAE-born …
Bright Pattern and Voxtron Join Forces to Showcase AI-Powered Omnichannel CX Innovation at GITEX GLOBAL 2025
EIN Presswire
·
August 25, 2025
DUBAI, UNITED ARAB EMIRATES, August 24, 2025 /EINPresswire.com/ -- Bright Pattern, the leading provider of AI-powered omnichannel contact center solutions, and Voxtron, a pioneer of communication products in Dubai, UAE, are excited to announce their …
Intercare Chemicals Unveils Care ECO Laundry Pods
EIN Presswire
·
August 25, 2025
Intercare launches Care ECO Laundry Pods in UAE — plant-based, 3-in-1 cleaning, eco-packaging …
ParaZero Concluded Another Field Test Demonstrating 100% Success Rate in Countering Hostile Drone Threats on Critical and Sensitive Infrastructure
GlobeNewswire
·
August 25, 2025
Kfar Saba, Israel, Aug. 25, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) …
Palisade Bio Releases Virtual Investor KOL Connect Segment on FSCD and Lead Candidate PALI-2108
GlobeNewswire
·
August 25, 2025
– Moderated discussion with leading expert in Fibrostenotic Crohn's Disease (FSCD) and Inflammatory Bowel Diseases (IBD), Dr. Brian Feagan – Segment provides further insight into the need for more effective treatment options for FSCD and how PALI-2108 may …
PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
GlobeNewswire
·
August 25, 2025
Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of care pembrolizumab or pembrolizumab + chemotherapy is 17.9 months* VERSATILE-003 Phase 3 trial in progress PRINCETON, N.J., Aug. 25, 2025 (GLOBE …
Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
GlobeNewswire
·
August 25, 2025
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More than 50 million people affected by acne in US each year, …
24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets
GlobeNewswire
·
August 25, 2025
DENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage …
Fiverr to Present at Upcoming Conference
GlobeNewswire
·
August 25, 2025
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR), the company that is transforming the way the world creates and works together, today announced that Micha Kaufman, Founder and Chief Executive Officer, will present at the …
SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025
GlobeNewswire
·
August 25, 2025
JERSEY CITY, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Scynexis senior …
Ardelyx to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
ORYZON Receives European Medicines Agency Approval to Initiate a Phase Ib Study of Iadademstat in Sickle Cell Disease
GlobeNewswire
·
August 25, 2025
First iadademstat clinical trial in non-malignant hematological indications MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a …
Avalyn to Participate in Multiple Upcoming Investor Conferences in September
GlobeNewswire
·
August 25, 2025
CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management …
Fate Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 25, 2025
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular …